|
Title
|
Published
|
Price
|
|
Sanofi-Aventis SA (SNY) Profile & Biotech Industry Trends Analysis 2010
By: Plunkett Research, Ltd.
This summary contains complete trends chapters excerpted from Plunkett's Biotech & Genetics Industry Almanac. Wield this tool for strategic planning, business development, or industry analysis. It includes our analysis of the major trends
|
more...
Search inside this report
|
11/18/2009
|
$149.99
|
|
Biotechnology Sector
By: First Research, Inc.
The US biotechnology industry includes about 1,500 companies with combined annual revenue of about $70 billion. Major companies include Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), Genzyme, Life Technologies, and Monsanto. Because many drugs
|
more...
Search inside this report
|
11/16/2009
|
$129.00
|
|
Monoclonal antibodies: 2009 update
By: Datamonitor
Introduction The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2014 and assessing trends by product, company, therapy area, geography, technology and target type. It also
|
more...
|
11/2/2009
|
$7,600.00
|
|
Opportunities in Human Embryonic Stem Cell (hESC) Products
By: BioInformant Worldwide, L.L.C.
Human embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, which is a stage reach 4-5 days post fertilization. They are the most pluripotent of all stem cell
|
more...
Search inside this report
|
11/1/2009
|
$3,495.00
|
|
United States Biotechnology Industry - Porter’s Five Forces Strategy Analysis
By: Aruvian's R'search
The rapidly emerging biotechnology industry is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes that are relieving human suffering, improving health, and increasing the
|
more...
Search inside this report
|
11/1/2009
|
$175.00
|
|
Stem Cell Therapies: Commercial R & D Mega Pipeline Report
By: BioPolaris
Stem cell therapies are relatively new and fast developing field. There is huge interest among general public,
patients suffering from incurable and difficult to cure diseases, professionals, scientists and investors in this area
of therapeutic
|
more...
Search inside this report
|
11/1/2009
|
$4,500.00
|
|
China Pharma Outsourcing Annual Review 2009
By: JZMed, Inc.
It has been well recognized that 2009 is a rough year to all types of industries worldwide. The financial crisis has significantly altered both pharmaceutical and biotechnology industries on global scale. The pharma
|
more...
|
11/1/2009
|
$1,385.00
|
|
Global Stem Cell and Advanced Technologies Market
By: MarketsandMarkets
The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and
|
more...
Search inside this report
|
11/1/2009
|
$4,650.00
|
|
Biotechnology in Australia - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Biotechnology in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating
|
more...
Search inside this report
|
10/17/2009
|
$810.00
|
|
Scientific Research & Development in the US - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Scientific Research & Development in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise,
|
more...
Search inside this report
|
10/17/2009
|
$825.00
|
|
Scientific Research in Australia - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Scientific Research in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business
|
more...
Search inside this report
|
10/17/2009
|
$810.00
|
|
Biotechnology in the US - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Biotechnology in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business
|
more...
Search inside this report
|
10/17/2009
|
$825.00
|
|
Biotechnology: Global Industry Guide
By: Datamonitor
Datamonitor's Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive
|
more...
Search inside this report
|
10/14/2009
|
$1,495.00
|
|
Biomarker and Diagnostic Opportunities in Clinical Research for Neurological Diseases
By: Decision Resources
Introduction
Biomarkers and imaging tools are enabling technologies in today’s clinical research efforts for neurological
diseases. Whether to improve upon existing methods for monitoring disease progression or to discover validated
measures to detect diseases earlier
|
more...
|
10/13/2009
|
$2,250.00
|
|
Worldwide Biotech - October 2009
By: Worldwide Videotex
Worldwide Biotech provides news and information on biotechnology as an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest
|
more...
Search inside this report
|
10/1/2009
|
$25.00
|
|
Advances in the Stem Cell Industry: The future impact of innovation, and an evaluation of the commercial landscape
By: Business Insights
An important milestone in the development of stem cell technology occurred in 2007, when researchers induced human cells into a stem cell state using defined genetic factors. These cells are now known as induced pluripotent
|
more...
Search inside this report
|
10/1/2009
|
$3,835.00
|
|
Drug Delivery Partnering Agreements in Pharma and Biotech
By: CurrentPartnering
The Drug Delivery Partnering Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds leading healthcare companies.
The report provides a
|
more...
Search inside this report
|
10/1/2009
|
$2,395.00
|
|
VWR International Inc.
By: SGA Lists
VWR International is a leading global laboratory supply company. VWR International`s business is highly diversified across products and services, geographic regions and customer segments. The company offers products from a wide range of manufacturers to
|
more...
|
10/1/2009
|
$40.00
|
|
The Evolving Life Science Researcher - At the Cusp of Transformation
By: IDC
This Health Industry Insights Perspective highlights past researcher best practices and future expectations for the changing role of the individual researcher in the life science industry as companies and their researchers incrementally adapt to help
|
more...
Search inside this report
|
9/28/2009
|
$1,500.00
|
|
Rethinking Pharmaceutical R&D: Will New Strategies Yield a Pipeline Payoff?
By: Decision Resources
Introduction
Can radical changes to the structures and strategies of pharmaceutical R&D operations—such as
creating more entrepreneurial environments modeled upon biotech companies—increase their productivity?
Many major companies are reorganizing the research branches of their businesses
|
more...
|
9/18/2009
|
$2,250.00
|
|
Global Biotechnology
By: IBISWorld
Industry Market Research Synopsis This Industry Market Research report from IBISWorld provides a detailed analysis of the Global Biotechnology industry, including key growth trends, statistics, forecasts, the competitive environment including market shares and the key issues
|
more...
Search inside this report
|
9/16/2009
|
$825.00
|
|
The Future of White Biotechnology in China
By: CCM International Limited
The future of white Biotechnology is attractive in China, and considerable progress in white biotechnology has been made in recent years. China’s production of many vitamins and polysaccharides products is now in a leading position
|
more...
|
9/2/2009
|
$12,150.00
|
|
Biotechnology in France
By: Datamonitor
Datamonitor's Biotechnology in France industry profile is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the
|
more...
Search inside this report
|
9/2/2009
|
$250.00
|
|
Biotechnology in the United States
By: Datamonitor
Datamonitor's Biotechnology in the United States industry profile is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis
|
more...
Search inside this report
|
9/2/2009
|
$250.00
|
|
Biotechnology in the Netherlands
By: Datamonitor
Datamonitor's Biotechnology in the Netherlands industry profile is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of
|
more...
Search inside this report
|
9/2/2009
|
$250.00
|
|
Title
|
Published
|
Price
|
(0 items)
